AlphaYou
Overview
Smart money at a glance
Filings to Oct 11, 2026Net selling: insiders sold $5K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$5K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 10- Open
- $1.16
- 52-wk high
- $2.66
- High
- $1.29
- 52-wk low
- $1.05
- Low
- $1.15
- Prev close
- $1.18
- Mkt cap
- $172.8M
- Volume
- 1.22M
- Beta
- 0.48
- P/S
- 5086.0x
- P/B
- 1.5x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -80.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ALXO filings
Are insiders buying or selling Alx Oncology Holdings (ALXO) stock?
Net selling: insiders sold $5K and bought $0 of ALXO stock on the open market in the 90 days to Oct 11, 2026, according to SEC Form 4 filings. The largest was Lettmann, Jason (Chief Executive Officer), who sold $4K. The latest filing was on Aug 18, 2026.
Which members of Congress have traded ALXO recently?
None. No member of Congress disclosed a ALXO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ALXO smart-money data?
This summary uses filings available on Oct 11, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BR
BlackRock
$14.4M
added
What insiders are doing
How top traders are positioned
No tracked top-trader positions in ALXO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
Reports Nov 6, 2026, in 26 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $173M
Valuation
- P/S5085.96
- P/B1.47
Quality
- Operating margin0.0%
- ROE-80.6%
- ROA-40.4%
Growth
- Beta0.48
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace